**Question:** Ipratropium bromide is contraindicated in:

A. Obstructive sleep apnoea
B. Glaucoma
C. Myasthenia gravis
D. Cardiovascular disease

**Core Concept:**
Ipratropium bromide is a bronchodilator drug used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is a selective muscarinic antagonist that competitively inhibits the action of acetylcholine on muscarinic receptors in the bronchial smooth muscles, leading to bronchodilation and relief of airway obstruction.

**Why the Correct Answer is Right:**
Ipratropium bromide is contraindicated in myasthenia gravis (option C) because it can cause exacerbation of the disease by blocking the parasympathetic muscarinic receptors and impairing the neuromuscular transmission, which is already compromised in myasthenia gravis. In healthy individuals, ipratropium bromide is beneficial as it helps to relieve airway obstruction.

**Why Each Wrong Option is Incorrect:**
Option A (obstructive sleep apnoea) is incorrect because ipratropium bromide does not directly affect sleep apnoea, a condition caused by anatomical abnormalities and not directly related to muscarinic receptor blockade.

Option B (glaucoma) is incorrect because ipratropium bromide is not known to increase intraocular pressure in healthy individuals. However, in patients with pre-existing glaucoma or increased intraocular pressure, it could potentially worsen the condition by blocking the parasympathetic muscarinic receptors in the eye, leading to increased intraocular pressure.

Option D (cardiovascular disease) is incorrect because ipratropium bromide does not have significant cardiovascular effects in healthy individuals. However, in patients with pre-existing cardiovascular disease, it could potentially cause adverse effects like bradycardia, hypotension, and electrolyte imbalances.

**Clinical Pearl:**
Ipratropium bromide is generally safe and well-tolerated in most individuals. However, clinicians should take into consideration the contraindications mentioned above while prescribing the drug for patients with coexisting diseases or those with pre-existing conditions. It is essential to assess the potential risks against the benefits before prescribing ipratropium bromide and choose the appropriate therapy based on the patient's overall health status.